CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
November 2020—Bio-Rad Laboratories launched its in vitro diagnostics Virotrol SARS-CoV-2 and Viroclear SARS-CoV-2 positive and negative quality controls for use in antibody testing of SARS-CoV-2. The serological controls are available for in vitro assay procedures in the U.S. and are CE marked for IVD markets outside the U.S.
Virotrol SARS-CoV-2 quality controls are independent, positive controls designed to detect antibodies for SARS-CoV-2. The controls can detect SARS-CoV-2 total IgM and IgG antibodies across all testing procedures. They are available in three classes, each targeted to specific levels of the SARS-CoV-2 antibodies to match the range of commercially available assays.
Pages: 1 2